{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T19:01:36Z","timestamp":1760122896319,"version":"3.44.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajconline.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Cardiology"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.amjcard.2019.11.004","type":"journal-article","created":{"date-parts":[[2019,11,19]],"date-time":"2019-11-19T02:15:39Z","timestamp":1574129739000},"page":"553-561","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Comparison of Long-Term Adverse Outcomes in Patients With Atrial Fibrillation Having Ablation Versus Antiarrhythmic Medications"],"prefix":"10.1016","volume":"125","author":[{"given":"James V.","family":"Freeman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Grace H.","family":"Tabada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7619-1649","authenticated-orcid":false,"given":"Kristi","family":"Reynolds","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sue Hee","family":"Sung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel E.","family":"Singer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul J.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taylor I.","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nigel","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark A.","family":"Hlatky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alan S.","family":"Go","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjcard.2019.11.004_bib0001","first-page":"e199","article-title":"2014 AHA\/ACC\/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology\/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society","volume":"130","author":"January","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2019.11.004_bib0002","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1161\/CIRCOUTCOMES.110.957563","article-title":"Improvements in symptoms and quality of life in patients with paroxysmal atrial fibrillation treated with radiofrequency catheter ablation versus antiarrhythmic drugs","volume":"3","author":"Reynolds","year":"2010","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.amjcard.2019.11.004_bib0003","doi-asserted-by":"crossref","DOI":"10.1136\/openhrt-2015-000302","article-title":"Effect of catheter ablation on quality of life in patients with atrial fibrillation and its correlation with arrhythmia outcome","volume":"2","author":"Raine","year":"2015","journal-title":"Open Heart"},{"key":"10.1016\/j.amjcard.2019.11.004_bib0004","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.1016\/j.jacc.2010.01.040","article-title":"Long-term quality of life after ablation of atrial fibrillation the impact of recurrence, symptom relief, and placebo effect","volume":"55","author":"Wokhlu","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2019.11.004_bib0005","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1001\/jama.2019.0693","article-title":"Effect of catheter ablation vs antiarrhythmic drug therapy on mortality, stroke, bleeding, and cardiac arrest among patients with atrial fibrillation: The CABANA randomized clinical trial","volume":"321","author":"Packer","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/j.amjcard.2019.11.004_bib0006","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1161\/CIRCULATIONAHA.115.019406","article-title":"Ablation versus amiodarone for treatment of persistent atrial fibrillation in patients with congestive heart failure and an implanted device: results from the AATAC multicenter randomized trial","volume":"133","author":"Di Biase","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2019.11.004_bib0007","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1056\/NEJMoa1707855","article-title":"Catheter ablation for atrial fibrillation with heart failure","volume":"378","author":"Marrouche","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjcard.2019.11.004_bib0008","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1111\/j.1540-8167.2011.02035.x","article-title":"Patients treated with catheter ablation for atrial fibrillation have long-term rates of death, stroke, and dementia similar to patients without atrial fibrillation","volume":"22","author":"Bunch","year":"2011","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.amjcard.2019.11.004_bib0009","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1016\/j.hrthm.2013.07.002","article-title":"Atrial fibrillation ablation patients have long-term stroke rates similar to patients without atrial fibrillation regardless of CHADS2 score","volume":"10","author":"Bunch","year":"2013","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.amjcard.2019.11.004_bib0010","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.1093\/eurheartj\/ehw087","article-title":"Catheter ablation for atrial fibrillation is associated with lower incidence of stroke and death: data from Swedish health registries","volume":"37","author":"Friberg","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.amjcard.2019.11.004_bib0011","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.117.005739","article-title":"CAABL-AF (California Study of Ablation for Atrial Fibrillation): mortality and stroke, 2005 to 2013","volume":"11","author":"Srivatsa","year":"2018","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.amjcard.2019.11.004_bib0012","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.115.001901","article-title":"Catheter ablation of atrial fibrillation in U.S. Community Practice\u2014results from Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF)","volume":"4","author":"Holmqvist","year":"2015","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.amjcard.2019.11.004_bib0013","first-page":"507","article-title":"Long-term stroke rates after catheter ablation or antiarrhythmic drug therapy for atrial fibrillation: a meta-analysis of randomized trials","volume":"12","author":"Zheng","year":"2015","journal-title":"J Geriatr Cardiol"},{"key":"10.1016\/j.amjcard.2019.11.004_bib0014","doi-asserted-by":"crossref","first-page":"37","DOI":"10.7812\/TPP\/12-031","article-title":"Sociodemographic characteristics of members of a large, integrated health care system: comparison with US Census Bureau data","volume":"16","author":"Koebnick","year":"2012","journal-title":"Perm J"},{"key":"10.1016\/j.amjcard.2019.11.004_bib0015","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1161\/CIRCOUTCOMES.108.801654","article-title":"The Cardiovascular Research Network: a new paradigm for cardiovascular quality and outcomes research","volume":"1","author":"Go","year":"2008","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.amjcard.2019.11.004_bib0016","doi-asserted-by":"crossref","first-page":"2713","DOI":"10.1161\/CIRCULATIONAHA.105.577577","article-title":"Hemoglobin level, chronic kidney disease, and the risks of death and hospitalization in adults with chronic heart failure: the Anemia in Chronic Heart Failure: outcomes and resource utilization (ANCHOR) study","volume":"113","author":"Go","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2019.11.004_bib0017","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1097\/EDE.0b013e3181a663cc","article-title":"High-dimensional propensity score adjustment in studies of treatment effects using health care claims data","volume":"20","author":"Schneeweiss","year":"2009","journal-title":"Epidemiology"},{"key":"10.1016\/j.amjcard.2019.11.004_bib0018","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1136\/jamia.1997.0040233","article-title":"Use of commercial record linkage software and vital statistics to identify patient deaths","volume":"4","author":"Newman","year":"1997","journal-title":"J Am Med Inform Assoc"},{"key":"10.1016\/j.amjcard.2019.11.004_bib0019","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.2105\/AJPH.74.12.1324","article-title":"The California Automated Mortality Linkage System (CAMLIS)","volume":"74","author":"Arellano","year":"1984","journal-title":"Am J Public Health"},{"key":"10.1016\/j.amjcard.2019.11.004_bib0020","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1056\/NEJMoa041031","article-title":"Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization","volume":"351","author":"Go","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjcard.2019.11.004_bib0021","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.2337\/diacare.20.9.1396","article-title":"Excess costs of medical care for patients with diabetes in a managed care population","volume":"20","author":"Selby","year":"1997","journal-title":"Diabetes Care"},{"key":"10.1016\/j.amjcard.2019.11.004_bib0022","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1001\/jama.285.19.2486","article-title":"Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)","volume":"285","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.amjcard.2019.11.004_bib0023","doi-asserted-by":"crossref","first-page":"247","DOI":"10.7326\/0003-4819-145-4-200608150-00004","article-title":"Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate","volume":"145","author":"Levey","year":"2006","journal-title":"Ann Intern Med"},{"issue":"2 Suppl 1","key":"10.1016\/j.amjcard.2019.11.004_bib0024","first-page":"S1","article-title":"K\/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification","volume":"39","year":"2002","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.amjcard.2019.11.004_bib0025","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1093\/jnci\/92.2.136","article-title":"Cost of care for patients in cancer clinical trials","volume":"92","author":"Fireman","year":"2000","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.amjcard.2019.11.004_bib0026","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate","volume":"150","author":"Levey","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.amjcard.2019.11.004_bib0027","doi-asserted-by":"crossref","first-page":"2415","DOI":"10.1001\/archinternmed.2008.506","article-title":"Comparative effectiveness of different beta-adrenergic antagonists on mortality among adults with heart failure in clinical practice","volume":"168","author":"Go","year":"2008","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.amjcard.2019.11.004_bib0028","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.amjcard.2017.11.034","article-title":"Contemporary procedural complications, hospitalizations, and emergency visits after catheter ablation for atrial fibrillation","volume":"121","author":"Freeman","year":"2018","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjcard.2019.11.004_bib0029","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1161\/CIRCULATIONAHA.108.839639","article-title":"Antiarrhythmics after ablation of atrial fibrillation (5A study)","volume":"120","author":"Roux","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2019.11.004_bib0030","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/j.hrthm.2007.04.005","volume":"4","author":"Calkins","year":"2007","journal-title":"Heart Rhythm"}],"container-title":["The American Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914919312962?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914919312962?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T06:32:24Z","timestamp":1757572344000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002914919312962"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["S0002914919312962"],"URL":"https:\/\/doi.org\/10.1016\/j.amjcard.2019.11.004","relation":{},"ISSN":["0002-9149"],"issn-type":[{"type":"print","value":"0002-9149"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of Long-Term Adverse Outcomes in Patients With Atrial Fibrillation Having Ablation Versus Antiarrhythmic Medications","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjcard.2019.11.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}